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Effective priming of T cell responses depends on cognate interactions between naive T cells 
and professional antigen-presenting cells (APCs). This contact is the result of highly 
coordinated migration processes, in which the chemokine receptor CCR7 and its ligands, 
CCL19 and CCL21, play a central role. We used the murine 
 
Listeria monocytogenes
 
 infection 
model to characterize the role of the CCR7/CCR7 ligand system in the generation of T cell 
responses during bacterial infection. We demonstrate that efficient priming of naive major 
histocompatibility complex (MHC) class Ia–restricted CD8
 

 
 T cells requires CCR7. In 
contrast, MHC class Ib–restricted CD8
 

 
 T cells and MHC class II–restricted CD4
 

 
 T cells 
seem to be less dependent on CCR7; memory T cell responses are independent of CCR7. 
Infection experiments with bone marrow chimeras or mice reconstituted with purified T cell 
populations indicate that CCR7 has to be expressed on CD8
 

 
 T cells and professional APCs to 
promote efficient MHC class Ia–restricted T cell priming. Thus, different T cell subtypes and 
maturation stages have discrete requirements for CCR7.
 
Close contact between naive T cells and pro-
fessional APCs is a prerequisite for effective T
cell priming. This contact does not occur ran-
domly, but rather is a consequence of highly
coordinated migration processes which involve
different adhesion molecules and chemokine/
chemokine receptor systems. The chemokine
receptor CCR7, and its ligands, CCL19 (EBV-
induced gene 1 ligand chemokine, macro-
phage inflammatory protein-3
 

 
) and CCL21
(secondary lymphoid tissue chemokine, 6Ckine),
seem to play a central role (1, 2). CCR7 is ex-
pressed on naive T cells, a subpopulation of
memory T cells, and B cells (1). Immature
dendritic cells do not express CCR7; however,
during maturation, CCR7 is up-regulated on
their surface (3). CCL19 and CCL21 are secreted
by stromal cells that are located in the T cell
zones of secondary lymphoid organs. In addi-
tion, CCL21 is expressed by high endothelial
venules and the lymphatic endothelium (1, 2,
4). Standard laboratory mouse strains express at
least two isoforms of CCL21—CCL21-Ser
and CCL21-Leu—which are encoded by in-
dependent genes. In contrast to CCL21-Ser,
expression of CCL21-Leu is restricted to the
lymphatic epithelium of peripheral tissues (4).
After chemokine attraction, naive T cells and
activated dendritic cells enter lymphoid tissues
and migrate along the CCL19/CCL21 gradients
into T cell zones, where cognate interactions
eventually occur (1, 2, 5).
The concept of chemokine-controlled T
cell priming is supported by observations in
CCR7-deficient mice and in 
 
plt
 
 (paucity of
lymph node T cell) mice, which fail to express
CCL19 and CCL21-Ser and show impaired
expression levels of CCL21-Leu (4, 6–9). In
both mouse strains, T lymphocytes home
poorly into lymph nodes and Peyer’s patches,
and inside lymph nodes, T cells are distributed
aberrantly (4, 6, 8). Although T cells can still
enter the spleen, these mice fail to develop dis-
tinct T cell zones in the white pulp (4, 6). Fur-
thermore, migration of mature dendritic cells
into secondary lymphoid tissues is impaired (3,
6). Consequently, both mouse strains demon-
strate altered acquired immune responses. In
CCR7-deficient mice, delayed-type hypersensi-
tivity reactions are reduced, and T cell dependent
antibody production is delayed (6). CCR7
mice fail to reject allogeneic tumors and rejec-
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tion of grafted allogeneic hearts is delayed (9). In 
 
plt
 
 mice,
acquired immune responses seem to be affected less severely.
Although, 
 
plt
 
 mice are more susceptible to infection with
murine hepatitis virus (7), immune responses after infection
with lymphocytic choriomeningitis virus, vesicular stomatitis
virus, and different strains of vaccinia virus are similar to that
Figure 1. CD8 T cell response to primary L. monocytogenes infection. 
CCR7/ and CCR7/ mice on BALB/c background were infected i.v. with 
103 (A, B, D, E) or orally with 109 L. monocytogenes organisms (C). After 8 d, 
spleen cells (A, B) or cells isolated from liver, lamina propria, and epithelium 
of the small intestine (C) were stained with FITC-conjugated anti-CD62L mAb, 
Cy5-conjugated anti-CD8 mAb, and PE-conjugated LLO91–99 tetramers. Cells 
were analyzed by flow cytometry after the addition of propidium iodide. 
(A) CD8-gated representative results. Numbers give the percent of cells 
within the region and are calculated for CD8 T cells only. (B, C) The percent 
of LLO91–99-tetramer CD62Llow of CD8 T cells and absolute number of 
LLO91–99-tetramer CD62Llow CD8 T cells per spleen (mean  SD of three 
independently analyzed mice per group). In addition, spleen cells were incu-
bated for 5 h with the peptides LLO91–99 or p60217–225 (D, E). Cells were stained 
extracellularly with anti-CD8 mAb and intracellularly with anti-IFN mAb 
and analyzed by flow cytometry. (D) Representative results. Numbers give the 
frequencies for IFN of CD8 cells only. (E) Frequencies of IFN cells 
among CD8 T cells after in vitro incubation without (white bars) or with 
peptides LLO91–99 or p60217–225 (black bars; mean  SD of three individually 
analyzed mice per group). *Difference between cells from infected CCR7/ 
and CCR7/ mice was statistically significant (P  0.05).
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in control mice (8). Despite an aberrant T cell migration pat-
tern in infected 
 
plt
 
 mice, antiviral T cell and antibody re-
sponses are virtually normal, and 
 
plt
 
 mice can control viral
infections (8). Furthermore, immunization of 
 
plt
 
 mice with
ovalbumin results in delayed, but otherwise normal or even
stronger priming of CD4
 

 
 T cells (4). Overall, these studies
question the general requirement for CCR7/CCR7 ligands
interactions for T cell priming and point to more complex
functions during acquired immune responses.
Infection of mice with the intracellular bacterium 
 
Listeria
monocytogenes
 
 represents a valuable model to study T cell re-
sponses in vivo (10, 11). After infection, 
 
L.
 
 
 
monocytogenes
 
 mi-
grate to their main target organs—spleen and liver—where
they invade macrophages and hepatocytes. In these cells, 
 
L.
monocytogenes
 
 penetrate the phagosomal membrane and enter
the cytoplasm. Because of their intracytoplasmic habitat, 
 
L.
monocytogenes
 
–derived antigens are presented efficiently via
the MHC class I pathway; this results in the induction of a
potent CD8
 

 
 T cell response. CD8
 

 
 T cells are crucial for
the control of 
 
L. monocytogenes
 
 infection and are responsible
for protection against reinfection. In addition, a considerable
CD4
 

 
 T cell response is induced, although the role of this
cell population is less clear (12, 13). Several 
 
L. monocytogenes
 
–
derived T cell epitopes have been characterized, including
MHC class Ia–, MHC class Ib–, and MHC class II–presented
peptides (10, 14). The respective peptides have been used
extensively to study the kinetics and regulation of 
 
L. monocy-
togenes
 
–specific T cell responses during infection. These anal-
yses yielded extensive information on the effector and mem-
ory phases of 
 
L. monocytogenes
 
–specific CD4
 

 
 and CD8
 

 
 T
cell responses. However, the early events of T cell priming
remain largely unknown. Only limited information is avail-
able on the sites and the APC populations that are involved
in T cell priming and the requirements for T cell differentia-
tion into effector and memory cells (15–18).
We analyzed CCR7-deficient mice using the murine 
 
L.
monocytogenes
 
 infection model. We demonstrate that CCR7
has to be expressed on CD8
 

 
 T cells and professional APCs
to allow efficient MHC class Ia–restricted priming. In con-
trast, MHC class Ib–restricted CD8
 

 
 T cells and MHC class
II–restricted CD4
 

 
 T cells are less dependent, and memory
T cell responses are independent of CCR7.
 
RESULTS
 
CCR7
 

 
/
 

 
 mice backcrossed onto the BALB/c background
and CCR7
 

 
/
 

 
 BALB/c control mice were i.v. infected with
10
 
3
 
 
 
L. monocytogenes
 
 organisms, and the CD8
 

 
 T cell re-
sponse was analyzed using H-2K
 
d
 
 tetramers loaded with the
immunodominant peptide listeriolysin O (LLO)
 
91–99
 
 (19). 8 d
after infection, approximately 2% of all CD8
 

 
 splenocytes
from CCR7
 

 
/
 

 
 mice were LLO
 
91–99
 
 tetramer
 

 
 (Fig. 1, A
and B). Spleens of CCR7
 

 
/
 

 
 mice contained a total of 1.5–
2.0 
 

 
 10
 
5
 
 LLO
 
91–99
 
 tetramer
 

 
 CD8
 

 
 T cells. In contrast, fre-
quencies and numbers of LLO
 
91–99
 
 tetramer
 

 
 CD8
 

 
 T cells
in infected CCR7
 

 
/
 

 
 mice were reduced and were close to
background levels that were observed in noninfected animals
(Fig. 1, A and B). The impaired response in CCR7
 

 
/
 

 
 mice
was not restricted to the spleen. After oral infection, we ob-
served reduced cell numbers of LLO
 
91–99
 
 tetramer
 

 
 CD8
 

 
 T
cells in spleen, liver, and lamina propria and epithelium of
the small intestine (Fig. 1 C). Similar results were obtained at
d 9, 10, and 17 after infection, excluding that the low fre-
quencies of LLO
 
91–99
 
 tetramer
 

 
 CD8
 

 
 T cells were the re-
sult of a delayed T cell response in CCR7
 

 
/
 

 
 mice (unpub-
lished data).
In parallel to the tetramer assay, splenocytes from in-
fected CCR7
 

 
/
 

 
 and CCR7
 

 
/
 

 
 BALB/c mice were restim-
ulated in vitro with the peptides LLO
 
91–99
 
 and p60
 
217–225
 
,
an independent immunodominant 
 
L. monocytogenes
 
–derived
CD8
 

 
 T cell epitope (19). Stimulation with both peptides
induced IFN
 
 production in CD8 spleen cells from in-
fected control mice (Fig. 1, D and E). In contrast, only mar-
ginal frequencies of IFN CD8 T cells were observed in
spleens of CCR7/ mice; this confirmed the results from
the LLO91–99 tetramer assay and indicated that the impaired
response was not restricted to the LLO91–99 epitope.
Despite the marginal proportion of L. monocytogenes–specific
CD8 T cells, CCR7/ mice tolerated the L. monocytogenes
inoculum that was used in our experiments, and susceptibility
to infection was not increased substantially. CCR7/ mice
showed impaired clearance of L. monocytogenes with slightly
higher bacterial titers at late time points after infection (Fig.
2). However, at later time points (	10 d after infection),
CCR7/ and CCR7/ mice usually had cleared L. mono-
cytogenes from spleen and liver (unpublished data).
Infection of mice with L. monocytogenes results in the
generation of specific CD8 memory T cells, which mount
an accelerated and elevated anti–L. monocytogenes T cell re-
sponse to reinfection. To assess the role of CCR7 in the
Figure 2. Bacterial burdens in spleen and liver of CCR7/ mice 
after L. monocytogenes infection. CCR7/ (white bars) and CCR7/ 
mice (black bars) were i.v. infected with 103 L. monocytogenes organisms. 
On the indicated days, mice were killed and bacterial titers in spleen and 
liver were determined. Results represent the mean  SD of four or five 
mice per group. The dotted line gives the detection limit of our assay 
(40 bacteria/organ). *Difference between titers from infected CCR7/ and 
CCR7/ mice was statistically significant (P  0.05).
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generation and maintenance of CD8 memory T cells,
CCR7/ and CCR7/ BALB/c mice were infected with
103 L. monocytogenes organisms; 6 wk later, mice were chal-
lenged with 105 L. monocytogenes organisms. 6 d after second-
ary infection, CD8 T cell responses were analyzed with
LLO91–99 tetramers and by intracellular cytokine staining af-
ter in vitro restimulation with LLO91–99 or p60217–225 pep-
tides (Fig. 3). CCR7/ control mice demonstrated en-
Figure 3. CD8 T cell responses to LLO91–99 or p60217–225 after 
secondary L. monocytogenes infection. CCR7/ and CCR7/ mice on 
BALB/c background were infected i.v. with 103 L. monocytogenes organisms. 
After 44 d, mice were secondarily infected (i.v.) with 105 L. monocytogenes 
organisms. On day 6 after secondary infection, spleen cells were analyzed as 
described in Fig. 1. (A) Frequencies and absolute numbers of LLO91–99-
tetramer CD62Llow CD8 T cells in CCR7/ and CCR7/ BALB/c mice 
(mean  SD of three individually analyzed mice per group). (B) Frequencies 
of IFN cells among CD8 T cells after short-term incubation without 
(white bars) or with peptides LLO91–99 or p60217–225 (black bars; mean  SD 
of three individually analyzed mice per group). There was no significant dif-
ference (P 	 0.05) between CCR7/ and CCR7/ mice in frequencies and 
total cell numbers of LLO91–99-tetramer CD62Llow CD8 T cells (A), and in 
the frequencies of IFN-producing cells after peptide restimulation (B).
hanced frequencies and absolute numbers of LLO91–99- and
p60217–225-specific CD8 T cells, characteristic for secondary
responses. Despite the marginal primary responses, CD8 T
cell frequencies and total numbers in secondary infected
CCR7/ mice were similar to those in CCR7/ control
animals. As could be expected from the strong secondary
CD8 T cell response, all CCR7/ and CCR7/ animals
had cleared the infection from spleen and liver at the time
point of T cell analysis. Direct measurement of LLO91–99-
specific CD8 memory T cells 6 to 8 wk after infection was
difficult, because even in CCR7/ mice, numbers of mem-
ory cells in spleen and liver were close to the detection level
of our assay (unpublished data). To circumvent this prob-
lem, we used a recombinant L. monocytogenes strain that se-
cretes a truncated OVA protein (LmOVA) (20). Infection of
C57BL/6 mice with LmOVA results in a substantial CD8
T cell response to the OVA257–264-epitope and a high level
of CD8 memory T cells (21). As expected, we observed
a strong OVA257–264-specific CD8 T cell response in
CCR7/ C57BL/6 mice, but only a weak response in
CCR7/ C57BL/6 mice (Fig. 4 A). Reinfection of mice
caused an extensive secondary OVA257–264-specific CD8 T
cell response, which was reduced only slightly in CCR7/
mice compared with CCR7/ mice (Fig. 4 B). Analysis of
CD8 T cells from spleen and liver of mice 2 mo after
LmOVA infection revealed that both mouse strains had gen-
erated OVA257–264-specific memory T cells, although the fre-
quencies and numbers of these cells were reduced in
CCR7/ mice (Fig. 4 C).
Overall, these results indicate that CCR7/ mice can
generate significant CD8 memory T cell populations, de-
spite the marginal primary CD8 T cell response; this popu-
lation gives rise to rapid secondary responses after reinfec-
tion. In contrast to the primary response, the CD8 memory
T cell response seemed to be independent of CCR7.
In addition to CD8 T cell responses that are restricted
by conventional MHC class Ia molecules, L. monocytogenes
induces CD8 T cell responses that are restricted by MHC
class Ib molecules (10). So far, three L. monocytogenes–
derived formyl-methionine (f-met) peptides have been iden-
tified, which are recognized by H2-M3–restricted CD8 T
cells (10). Because the H2-M3–restricted response is far
more pronounced in C57BL/6 mice than in BALB/c mice
(22), CCR7/ mice backcrossed onto the C57BL/6 back-
ground were infected with 2  103 L. monocytogenes organ-
isms. 8 d after infection, spleen cells were incubated for 5 h
with a cocktail of the three L. monocytogenes–derived f-met
peptides (fMIGWII, fMIVIL, and fMIVTLF); frequencies of
IFN-producing CD8 T cells were determined by flow
cytometry (Fig. 5). In infected control mice, f-met peptides
induced IFN production in approximately 0.8% of the
CD8 splenocytes; this corresponded to 105 f-met–restricted
CD8 T cells per spleen. Significant frequencies of f-met–
restricted CD8 T cells also were present in spleens of in-
fected CCR7/ C57BL/6 mice. Although frequencies in
JEM VOL. 201, May 2, 2005 1451
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CCR7/ mice were reduced compared with controls, total
numbers did not differ significantly between both mouse
strains; this mainly was due to the enlarged spleen size of
CCR7/ mice (unpublished data). In two further experi-
ments, we consistently observed similar or only slightly re-
duced numbers of f-met–specific CD8 T cells in CCR7/
and CCR7/ mice (unpublished data). Thus, the lack of
CCR7 only marginally impaired f-met peptide–specific
CD8 T cell responses during L. monocytogenes infection.
The immunodominant I-Ab-restricted epitope LLO190–201
can be used for quantitative analysis of L. monocytogenes–
specific CD4 T cell responses in C57BL/6 mice (12).
CCR7/ and CCR7/ mice on C57BL/6 background
were infected with L. monocytogenes; 10 d after infection, fre-
quencies of LLO190–201-restricted CD4 T cells were deter-
mined (Fig. 6). In infected CCR7/ control mice, approx-
imately 0.6% of CD4 splenocytes produced IFN in
response to LLO190–201. Infected CCR7/ mice demon-
strated similar frequencies and total numbers of responding
cells (Fig. 6). When we analyzed CCR7/ and CCR7/
mice 8 or 9 d after infection, results were comparable (un-
published data). T cells from CCR7/ mice showed a ho-
Figure 4. CD8 T cell response to OVA257–264 after primary and 
secondary infection with LmOVA. CCR7/ and CCR7
 mice on 
C57BL/6 background were infected i.v. with 5  103 LmOVA organisms 
and 60 d later were challenged i.v. with 105 LmOVA organisms. 8 d after 
primary infection (A) and 6 d after secondary infection (B), frequencies 
and numbers of OVA257–264-specific CD8 T cells were determined in 
spleens of infected mice. (C) Frequencies and numbers of OVA257–264-
specific CD8 memory T cells in spleen and liver were measured 60 d after 
primary infection of mice. For comparison, we show values for naive 
CCR7/ animals. Mean SD of three individually analyzed mice per 
group. *Difference between infected CCR7/ and CCR7/ mice was 
statistically significant (P  0.05).
Figure 5. CD8 T cell response to f-met peptides during primary 
infection. CCR7/ and CCR7/ mice on C57BL/6 background were i.v. 
infected with 2  103 L. monocytogenes organisms. After 8 d, spleen cells 
were incubated for 5 h with a cocktail of the f-met peptides fMIGWII, 
fMIVIL and fMIVTLF. Cells were stained extracellularly with anti-CD8 mAb 
and intracellularly with anti-IFN mAb and analyzed by flow cytometry. 
The figure shows frequencies of IFN cells among CD8 T cells and total 
numbers of IFN CD8 T cells per spleen after incubation without (white 
bars) and with peptides (black bars; mean  SD of three individually 
analyzed mice per group). *Difference between IFN cells from infected 
CCR7/ and CCR7/ mice after restimulation with peptide was statisti-
cally significant (P  0.05).
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mogenous response in all six experiments, in which we ana-
lyzed CD4 T cell responses. In contrast, CD4 T cells from
CCR7/ mice demonstrated some variation. We observed
individual mice, in which the response was reduced up to
one third of the mean response of wild-type animals. How-
ever, in none of the experiments did the difference between
the mean response in CCR7/ and CCR7/ mice
reached a statistically significant level (P  0.05). In sum-
mary, our results demonstrate that MHC class II–restricted
CD4 T cell responses to L. monocytogenes are far less depen-
dent on CCR7 than are the corresponding MHC class Ia–
restricted CD8 T cell responses.
Because CCR7 is expressed on naive CD8 T cells and
on activated dendritic cells, we determined the role of CCR7
on CD8 T cells in an adoptive T cell transfer model. CD8
T cells from the TCR-transgenic mouse strain OT1 recog-
nize OVA257–264, the immunodominant CD8 T cell epitope
that is included in the truncated ovalbumin protein expressed
by LmOVA (20). To determine whether CCR7 expression
on CD8 T cells is sufficient for the induction of a response,
purified CD8 T cells from OT1 donors were labeled with
carboxyfluorescein succinimidyl ester (CFSE) and adoptively
transferred into CCR7/ and CCR7/ recipients. After 24 h,
mice were infected with LmOVA; 72 h later, proliferation
of transferred CD8 T cells was analyzed by flow cytometry
(Fig. 7). In noninfected CCR7/ animals, transferred T cells
maintained the CFSEhigh phenotype. Infection of CCR7/
recipients induced proliferation of CD8 donor cells as indi-
cated by the stepwise loss of CFSE staining. In noninfected
CCR7/ recipients, we detected a low level of donor
cell proliferation for which we currently have no explana-
tion. However, proliferation did not increase further upon
LmOVA infection. As was expected from the analysis of the
endogenous CD8 T cell response to LmOVA infection
(Fig. 4 A), the block in activation of transferred CD8 T cells
was incomplete in CCR7/ recipients. At day 4 after infec-
Figure 6. CD4 T cell response to LLO190–201 during primary infec-
tion. CCR7/ and CCR7/ mice on C57BL/6 background were i.v. infected 
with 2  103 L. monocytogenes organisms. After 10 d, spleen cells were 
incubated for 5 h with the peptide LLO190–201. Cells were stained extracellu-
larly with anti-CD4 mAb and intracellularly with anti-IFN mAb, and ana-
lyzed by flow cytometry. (A) Representative results. (B) Frequencies of 
IFN cells among CD4 T cells and absolute numbers of IFN CD4 cells 
per spleen after incubation without (white bars) and with peptide LLO190–201 
(black bars; mean  SD of three individually analyzed mice per group). 
There was no significant difference (P 	 0.05) between IFN cells from 
infected CCR7/ and CCR7/ mice after restimulation with peptide.
Figure 7. Expression of CCR7 on CD8 T cells is insufficient for 
T cell priming. CCR7/ and CCR7/ mice on C57BL/6 background re-
ceived 4  106 purified CFSE-labeled CD8 T cells from OT1 mice. After 24 h, 
recipients were i.v. infected with 5  103 LmOVA organisms, or were left 
untreated (naive). 3 d later, spleen cells were stained with PE-conjugated 
OVA257–264 tetramers and Cy5-conjugated anti-CD8 mAb, and CFSE 
expression on transferred CD8 T cells was analyzed by flow cytometry. 
Figures show CD8-gated T cells only and are representative for two indi-
vidually analyzed mice per group.
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tion, some proliferation of donor cells also was observed in
CCR7/ recipients (unpublished data).
In a complementary set of experiments, we generated
bone marrow chimeras, in which TCR T cells had a
CCR7/ or a CCR7/ genotype. A similar approach re-
cently was described to analyze mutant B cells in a nonmu-
tant environment (23). TCR/ mice were irradiated and
reconstituted with bone marrow cells from TCR/ mice.
In addition, these animals received bone marrow cells from
either CCR7/ or CCR7/ mice at a 5:1 ratio of
TCR//CCR7/or TCR//CCR7/. Because of
this reconstitution protocol, the majority of hematopoietic
cells in the chimeras had a TCR/CCR7/ genotype.
In contrast, TCR T cells were exclusively CCR7/
or CCR7/. To confirm the mixed chimerism, bone mar-
row cells of TCR/ mice that were reconstituted with
TCR/ and CCR7/ bone marrow were T cell de-
pleted; DNA from these cells was analyzed by quantitative
PCR for the ratio of CCR7/(TCR/)/CCR7/ cells.
6 wk after reconstitution, we determined a ratio of 1:5.68 
0.74 (n  5) for CCR7/CCR7 DNA, a value which was
similar to the 1:5 ratio of bone marrow cells that was used
for the original reconstitution. 8 wk after reconstitution,
when mice showed normal T cell levels in the peripheral
blood, the chimeras were infected with LmOVA; 9 d later,
CD8 T cell responses were analyzed (Fig. 8). Mice that
were reconstituted with bone marrow cells from CCR7/
mice showed an OVA257–264-specific CD8 T cell response
similar to that observed in regular CCR7/ wild-type mice
(as shown in Fig. 4 A). In contrast, mice that were reconsti-
tuted with CCR7/ bone marrow cells demonstrated only
a marginal OVA257–264-specific CD8 T cell response. In
conclusion, the experiments that are shown in Figs. 7 and 8
indicate that CCR7 expression on MHC class Ia–restricted
CD8 T cells or on APCs alone is insufficient for efficient
priming. Rather, CCR7 has to be expressed on T cells and
APCs for effective induction of L. monocytogenes–specific
MHC class Ia–restricted CD8 T cells.
DISCUSSION
Using L. monocytogenes infection of CCR7/ mice, we
demonstrate differential requirements for the CCR7/CCR7
ligand system in the activation of different T cell subsets.
Naive MHC class Ia–restricted CD8 T cells depended
markedly on CCR7; MHC class Ib–restricted CD8 T cells
and MHC class II–restricted CD4 T cells showed some de-
pendency; activation of MHC class Ia–restricted CD8
memory T cells was virtually independent. The partial im-
pairment of the T cell response also is reflected by the rela-
tive resistance of CCR7/ mice during primary and sec-
ondary L. monocytogenes infection. Although CCR7/ mice
showed slightly higher L. monocytogenes titers at late time
points of primary infection, these mice could eradicate the
bacteria. Only 2 out of 	100 CCR7/ mice succumbed to
L. monocytogenes during the whole series of experiments,
which is similar to the normal range for wild-type mice.
The impaired CD8 T cell response was a general event
that was observed for all three L. monocytogenes–derived
MHC class Ia epitopes that were tested in our experiments
(LLO91–99, p60217–225, and the surrogate epitope OVA257–264).
The reduction was observed in all tissues that were analyzed
and at different time points following primary infection.
Thus, the impaired CD8 T cell response was neither due to
changes in the tissue distribution of the activated CD8 T
cells, which could be anticipated from the altered distribu-
tion pattern of T cells in CCR7/ mice (6), nor due to a
delayed response, which had been described for CD4 T
cells in plt mice (4). This result is in accordance with our ob-
servations in a tumor transplantation model, where CCR7/
mice failed to mount a CD8 T cell response against fully
allogeneic tumors (9). In contrast, Junt et al. did not detect
changes of the CD8 T cell responses in plt mice following
infection with different viruses (8). Currently, we only can
speculate on the reasons for the incongruent results. Differ-
ences in the cells that are involved in CD8 T cell priming,
the tissue localization of this process, and consequently, the
Figure 8. Expression of CCR7 on APCs is not sufficient for priming 
of CD8 T cells. TCR/ mice were irradiated and reconstituted with
10  106 bone marrow cells from TCR/ mice and 2  106 bone marrow 
cells from WT (CCR7/) or KO (CCR7/) mice. 8 wk after the reconstitu-
tion, mice were i.v. infected with 5  103 LmOVA organisms. After an 
additional 9 d, spleen cells were stained with FITC-conjugated anti-CD62L 
mAb, Cy5-conjugated anti-CD8 mAb, and PE-conjugated OVA257–264 tet-
ramers. Cells were analyzed by flow cytometry after addition of propidium 
iodide (mean  SD of three individually analyzed mice per group). *Differ-
ence between infected mice reconstituted with CCR7/ and CCR7/ 
bone marrow was statistically significant (P  0.05).
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requirement for CCR7 between viral and bacterial infec-
tions can be anticipated. The discrepancy also could be due
to the mouse strains that were used in the studies. The
CCR7-deficiency results in a complete breakdown of the
CCR7/CCR7 ligand system. In contrast, plt mice retain at
least one functional copy of CCL21, the CCL21-Leu (4,
24). Despite its limited expression pattern, CCL21-Leu
could be sufficient for effective priming of CD8 T cells.
In our infection model, CCR7/ mice generated re-
duced numbers of MHC class Ia–restricted CD8 memory T
cells when compared with wild-type animals. Considering
the marginal primary CD8 T cell response in CCR7/
mice, even this low number of CD8 memory T cells is sur-
prising. Our results, thus, argue against a strict correlation be-
tween the strength of the primary response and the size of the
memory cell population. According to current concepts,
CD8 memory T cells can be divided into two major sub-
populations: “effector” and “central” memory T cells (25).
Effector memory T cells possess a CCR7CD62Llow pheno-
type, are located mainly in nonlymphoid tissues, and show
rapid cytokine production and cytotoxicity following activa-
tion. In contrast, central effector cells are CCR7CD62Lhigh,
reside in secondary lymphoid tissues, and show delayed re-
sponses compared with effector memory T cells. Effector
memory T cells most likely represent a rapidly responding
cell population in the periphery, whereas central memory T
cells form the basis for stable CD8 T cell memory with high
proliferative capacity upon reactivation (25–28). The interre-
lation of both memory T cell populations is not clear, and
some studies even suggest a linear differentiation pathway
from CD8 effector T cells via effector memory intermedi-
ates to CD8 central memory T cells (29). In our infection
model, CCR7 was dispensable for the maintenance of CD8
memory T cells and the response of these cells after challenge
infection. However, this result does not challenge the current
concept of central and effector memory T cells. The lack of
CCR7 expression does not imply that there also is a lack of
CD8 central memory T cells. It is possible that even with-
out CCR7 expression, memory T cells can locate to niches,
which allows long-term survival. Furthermore, alternative
mechanisms could replace the CCR7/CCR7 ligands system.
Indeed, CXCL12 can facilitate homing of memory, but not
naive, T cells into secondary lymphoid tissues (30).
Despite the low number of MHC class Ia–restricted
CD8 memory T cells, CCR7/ mice showed virtually
normal secondary CD8 T cell responses. CD8 memory T
cells are responsible for rapid elimination of L. monocytogenes
following secondary infection. A small memory T cell popu-
lation controls L. monocytogenes less efficiently and results in a
greater abundance of bacterial antigens available for T cell
activation, more profound inflammation, and, consequently,
a stronger secondary T cell response. Such a compensatory
mechanism could explain the normal secondary CD8 T
cell response that is observed in CCR7/ mice. Overall,
our observations allow two general conclusions: (a) the
CCR7/CCR7 ligand system is not essential for generation
and survival of memory T cells. Accordingly, CCR7-medi-
ated migration of CD8 memory T cells into lymphoid tis-
sue is not a limiting factor for persistence of memory; and (b)
to a large extent, activation of CD8 memory T cells is in-
dependent of the CCR7/CCR7 ligands system. Thus, CD8
memory T cells seem to have less stringent requirements on
the environment of activation.
In contrast to the CD8 T cell response to conventional
MHC class Ia–restricted peptides, the response to f-met pep-
tides presented in the context of H2-M3 was impaired only
slightly by the absence of CCR7. H2-M3–restricted CD8
T cells recognize a broad range of structurally related f-met
peptides, and thus, are far more promiscuous than conven-
tional MHC class Ia–restricted CD8 T cells (31, 32). More-
over, H2-M3–restricted CD8 T cells display an activated
phenotype compared with conventional CD8 T cells
(33); in terms of magnitude and kinetics, H2-M3–restricted
CD8 T cell responses to L. monocytogenes resemble second-
ary responses rather than primary responses (22). Therefore,
H2-M3–restricted CD8 T cells could differ in their activa-
tion requirements, including a reduced dependency on
mechanisms that are mediated by the CCR7/CCR7 ligand
system. It also is possible that the H2-M3–restricted CD8 T
cell response to L. monocytogenes is due, at least in part, to the
activation of H2-M3–restricted CD8 memory T cells with
specificities to related f-met peptides. This notion is consis-
tent with our observations in CCR7/ mice. Because
CD8 memory T cell responses were largely independent of
CCR7, H2-M3–restricted responses only should be im-
paired partially in CCR7/ mice.
In comparison with the CD8 T cell response, the
CD4 T cell response against L. monocytogenes was affected
far less in CCR7/ mice, and in some animals, even
reached levels that were observed in control animals. Evi-
dence for CD4 T cell responses in the absence of the
CCR7/CCR7 ligands system has been described before.
CCR7/ and plt mice can generate T cell dependent anti-
body responses (6, 8, 9), and after immunization with oval-
bumin, spleen and lymph node cells of plt mice proliferate
and produce IL-2 in response to antigen restimulation (4).
Although plt mice lack distinct T cell zones in spleen and
lymph nodes, CD4 T cells and dendritic cells colocalize in
lymphoid tissues following immunization; this allows close
interactions, and, consequently, the priming of CD4 T cell
responses (4). A similar scenario could be envisaged in
CCR7/ mice following L. monocytogenes infection. Naive
CD4 T cells could interact with professional APCs that are
loaded with L. monocytogenes–derived antigens outside of dis-
crete T cell zones and result in the priming of L. monocytoge-
nes–specific CD4 T cells.
Expression of CCR7 is not restricted to naive T cells.
Our experiments demonstrate that neither CCR7 expression
on CD8 T cells in a CCR7-negative background nor ab-
sence of CCR7 on CD8 T cells in an otherwise CCR7-
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positive environment is sufficient for effective priming.
Upon activation, dendritic cells express CCR7 and dendritic
cell migration is impaired profoundly in CCR7/ and plt
mice. After immunization of these mice, dendritic cells fail
to enter lymph nodes, and in the spleen, activated dendritic
cells accumulate in the marginal zones rather than migrate
into the white pulp (3, 4, 6–8). In a histologic analysis of
spleens from L. monocytogenes–infected CCR7/ mice, we
detected similar alterations in dendritic cell distribution. 24
to 48 h after infection, dendritic cells entered the white pulp
and accumulated in the T cell zone of wild-type mice but
were trapped in the marginal zones of CCR7/ mice (un-
published data). Because dendritic cells are essential for
priming of CD8 T cells following L. monocytogenes infec-
tion (16, 17), the altered migration pattern of dendritic cells
could contribute to impaired priming. We conclude that
limitations in CD8 T cells and dendritic cells are responsi-
ble for the profound deficiency in the induction of MHC
class Ia–restricted CD8 T cell responses in CCR7/ mice.
In summary, our study demonstrates a discrete CCR7
requirement in the activation of different T cell subsets dur-
ing L. monocytogenes infection. This result indicates that there
is no general mechanism for the activation of T cells during
L. monocytogenes infection; rather different T cell subpopula-
tions have distinct requirements for the site and environment
in which the contact between APCs and T cells takes place.
MATERIALS AND METHODS
Antibodies. Rat IgG antibodies, anti-CD16/CD32 mAb (clone: 2.4G2),
anti-IFN mAb (R4-6A2, rat IgG1), anti-CD8 mAb (YTS169), anti-CD4
mAb (YTS191.1), anti-TCR mAb (H57-597), and anti-CD62L mAb
(Mel-14) were purified from rat serum or hybridoma supernatants with pro-
tein G–Sepharose. Antibodies were Cy5- or FITC-conjugated according to
standard protocols. Rat IgG1 isotype control mAb (clone: R3-34), anti-
CD11c mAb (clone HL3, Armenian hamster), and alkaline phosphatase–
conjugated rabbit anti–hamster Ig Ab were purchased from BD Biosciences.
Mice and L. monocytogenes infection. C57BL/6 and BALB/c and were
purchased from the Bundesinstitut für Risikobewertung (BfR) in Berlin.
OT1 mice (34) and TCR/ mice (35) were bred in our facilities. CCR7/
mice were crossed for six generations into the BALB/c background and for
eight generations into the C57BL/6 background (6, 9). The expression of
H-2Kd in CCR7/ BALB/c mice was confirmed by FACS analysis. CCR7/
mice were genotyped by PCR as described previously (6). All animal experi-
ments were conducted according to the German Animal Protection Law.
Mice were infected with L. monocytogenes strain EGD (Lm) or with
LmOVA (20). Bacteria were grown overnight in tryptic soy broth (TSB),
washed twice in PBS, resuspended in PBS 10% glycerol and stored at
80C. Aliquots were thawed and bacterial titers were determined by plat-
ing serial dilutions on TSB agar plates. For i.v. infection, L. monocytogenes
organisms were diluted appropriately and injected in a volume of 200 l
PBS into the lateral tail veins. For i.v. infection, L. monocytogenes was grown
overnight in TSB and washed twice in PBS. Bacterial density was deter-
mined by absorption at 600 nm and bacteria were diluted appropriately in
PBS (an OD600 value of 1 is equivalent to 109 bacteria/ml). Bacteria were
administered in 200 l PBS by gastric intubation. Bacterial inocula were
controlled by plating serial dilutions on TSB agar plates. For determination
of bacterial burdens in organs, mice were killed, organs were homogenized
in PBS, and serial dilutions of homogenates were plated on TSB agar. Col-
onies were counted after 24 h of incubation at 37C.
In vitro restimulation of cells and flow cytometric determination
of cytokine expression. Spleens were removed and single cell suspen-
sions were prepared using an iron mesh sieve. Red blood cells were lysed
and spleen cells were washed twice with RPMI 1640 medium supple-
mented with glutamine, Na-pyruvate, -mercaptoethanol, penicillin, strep-
tomycin, and 10% heat inactivated FCS (complete RPMI 1640 medium).
Isolation of T cells from liver and tissues of the small intestine (lamina pro-
pria lymphocyte and intraepithelial lymphocytes) was performed as de-
scribed previously (12). For determination of cytokine expression, 4  106
cells were cultured in a volume of 1 ml complete RPMI medium. Cells
were stimulated for 5 h with 106 M of the peptides LLO190–201
(NEKYAQAYPNVS), LLO91–99 (GYKDGNEYI), p60217–225 (KYGVS-
VQDI), OVA257–264 (SIINFEKL), or a cocktail of three f-met peptides that
were derived from L. monocytogenes proteins (fMIGWII, fMIVIL, and
fMIVTLF) (10). During the final 4 h of culture, 5 g/ml brefeldin A
(Sigma-Aldrich) were added. Cultured cells were washed and incubated for
10 min with rat IgG antibodies and anti-CD16/CD32 mAb to block non-
specific antibody binding. Subsequently, cells were stained with Cy5-conju-
gated anti-CD4 mAb or anti-CD8 mAb, and after 30 min on ice, cells
were washed with PBS and fixed for 20 min at room temperature with PBS
4% paraformaldehyde. Cells were washed with PBS 0.1% BSA, permeabi-
lized with PBS 0.1% BSA 0.5% saponin (Sigma-Aldrich), and incubated in
this buffer with rat IgG antibodies and anti-CD16/CD32 mAb. After 5
min, FITC-conjugated anti-IFN mAb or isotype control mAb were
added. After another 20 min at room temperature, cells were washed with
PBS and fixed with PBS 1% paraformaldehyde. Cells were analyzed using a
FACS-Calibur and the CELLQuest software (Becton Dickinson).
Generation of MHC class I tetramers and staining of cells with tet-
ramers. Modified forms of the full-length cDNA of H-2Kd, H-2Kb, and
human 2-m were provided by D. Busch, Institute for Microbiology, Im-
munology, and Hygiene, Technische Universität, München, Germany.
H-2Kd/LLO91-99 tetramers and H-2Kb/OVA257–264 tetramers were gener-
ated as described previously (19, 36). For flow cytometry analysis, 2  106
cells were incubated for 15 min at 4C with rat IgG Ab, anti-CD16/CD32
mAb, and streptavidin (Molecular Probes) in PBS 0.5% BSA 0.01% sodium
azide. After incubation, cells were stained for 60 min at 4C with Cy5-con-
jugated anti-CD8 mAb, FITC-conjugated anti-CD62L mAb, and PE-
conjugated MHC class I-LLO91–99 or OVA257–264 tetramers. Subsequently,
cells were washed with PBS 0.5% BSA 0.01% sodium azide and diluted
in PBS. Propidium iodide was added before four-color flow cytometry
analysis.
Cell transfer experiments. CD8 spleen cells from OT-1 mice were
purified by magnetic cell sorting ((MACS; Miltenyi Biotec) according to
the manufacturer’s protocol. Subsequently, cells were washed with PBS and
incubated for 4 min with 2 M of CFSE (Molecular Probes). Cells were
washed twice with complete medium, and 3–4  106 cells were injected
into the lateral tail vein of CCR7/C57BL/6 and control C57BL/6 mice.
1 d after the adoptive transfer, mice were i.v. infected with 5  103
LmOVA. 3 d after infection, mice were killed, spleen cells were stained
with PE-conjugated OVA257–264 tetramers and Cy5-conjugated anti-CD8
mAb and analyzed by four-color flow cytometry after the addition of pro-
pidium iodide.
Generation of bone marrow chimeras. For the generation of mixed
bone marrow chimeras, we used a protocol that was described recently by
Fillatreau and Gray (23). TCR/ mice on the C57BL/6 background
were irradiated with 600 rad. Subsequently, mice were reconstituted with
10  106 bone marrow cells from TCR/ mice. In addition, mice re-
ceived 2  106 bone marrow cells from wild-type C57BL/6 mice or from
CCR7/ mice. Before injection, the bone marrow from wild-type and
CCR7/ mice was T cell depleted by MACS according to the manufac-
turer’s protocol (CD90 depletion kit; Miltenyi Biotec). Mice were kept for
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4 wk on 2 mg/ml ampicillin and 1 mg/ml neomycin sulfate in the drinking
water. After 6–8 wk, reconstitution was controlled in the peripheral blood
by flow cytometry. Bone marrow chimeras were infected i.v. with 5  103
LmOVA and analyzed 9 d later. To verify the degree of chimerism, bone
marrow cells from TCR/ mice that were reconstituted with TCR/
and CCR7/ bone marrow cells were isolated, and CD90 T cells were
depleted by MACS. Genomic DNA from T cell–depleted bone marrow
cells was prepared by phenol chloroform extraction and dissolved in water.
Primers were designed to detect the intact CCR7 locus (CCR7) (forward:
5-AGAAGAACAGCGGCGAGGA-3, reverse: 5-AGCATAGGCAC-
TAGGAACCCAAA-3) or the deficient CCR7 locus (CCR7) (forward:
5-CAGTTTCATAGCCTGAAGAACGA-3, reverse: 5-GCCGAT-
GAAGGCATACAAGAAA-3). 10 ng of DNA from bone marrow cells of
CCR7/ animals were mixed with DNA from bone marrow cells of
CCR7/ (TCR/) animals at the ratios 2:1, 1:1, 1:2, 1:4, 1:8, 1:12, and
1:16. These mixtures and the DNA samples from T cell depleted bone mar-
row cells from the chimeras were analyzed in parallel by real-time PCR
(SYBR green, ABI Prism 7000, Becton Dickinson) using the primers spe-
cific for the CCR7 and the CCR7 locus. A curve was prepared by plot-
ting the numbers of cycle differences (CT) between the two primer pairs
against the mixing factor of the two DNA samples. An exponential function
was fitted onto the resulting curve using Excel (Microsoft). This function
(e.g., dilution  1.2675  100.8608xCT, R2  0.9995) was used to calculate
the ratio of CCR7/CCR7 DNA within T cell depleted bone marrow of
reconstituted animals.
Statistical analysis. All experiments described were performed at least
three times with similar results. Unless otherwise stated, experimental
groups consisted of at least three mice per group, and mice were analyzed
independently. For statistical analysis of frequencies and cell numbers we
applied the Student’s t test. Bacterial titers were compared using the Mann-
Whitney test. Differences were considered significant with P  0.05.
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